2020
Precision Dosing of Rapid-Acting Insulin Matters
Aanstoot HJ, Rodriguez H, Weinzimer S, Vint N, Koeneman L. Precision Dosing of Rapid-Acting Insulin Matters. Diabetes Technology & Therapeutics 2020, 22: 346-351. PMID: 32125891, DOI: 10.1089/dia.2019.0374.Peer-Reviewed Original ResearchConceptsGood glycemic controlGlycemic controlHalf-unit insulin pensInsulin pensDiabetes managementInsulin deliveryStringent glycemic controlInadequate glycemic controlType 2 diabetesType 1 diabetesPrecision of dosingDelivery devicesInsulin delivery devicesInsulin therapyGeriatric patientsHypoglycemic eventsPatient preferencesFlexible dosingPhysical activityDosingLiterature searchPrecision dosingDiabetesInsulinCorrective doses
2018
Sotagliflozin in Combination with Optimized Insulin Therapy Reduced HbA1c Levels with a Decreased Daily Insulin Requirement after 52 Weeks in Adults with T1D
PETTUS J, WEINZIMER S, MCCRIMMON R, AMPUDIA BLASCO F, STEWART J, STRUMPH P, OLIVEIRA J, LAPUERTA P, CASTRO R. Sotagliflozin in Combination with Optimized Insulin Therapy Reduced HbA1c Levels with a Decreased Daily Insulin Requirement after 52 Weeks in Adults with T1D. Diabetes 2018, 67 DOI: 10.2337/db18-5-lb.Peer-Reviewed Original ResearchInsulin dose changesDaily insulin doseTotal daily insulin doseOptimized insulin therapyInsulin doseInsulin therapySevere hypoBolus insulinGlycemic controlLexicon PharmaceuticalsMycotic infectionsDose changesTreatment-emergent adverse eventsInsulin reductionLS meanDaily insulin requirementGenital mycotic infectionsSanofi-AventisAdequate glycemic controlGood glycemic controlBody mass indexRisk of hypoglycemiaRenal glucose reabsorptionNumber of patientsType of insulin